A meta-analysis included 10 cross-sectional studies and showed no significant difference in the serum CRP level between AD patients and normal controls, whereas patients with mild and moderate AD had lower serum CRP levels as compared with the healthy controls by Mini-Mental State Examination scores (15), indicating that the diagnostic value of CRP for mild and moderate AD may be useful in clinical practice. The gene discussed is CRP; the disease is Alzheimer disease.